{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:24:05Z","timestamp":1770823445779,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Clin Oncol"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1038\/ncponc0910","type":"journal-article","created":{"date-parts":[[2007,8,29]],"date-time":"2007-08-29T16:58:30Z","timestamp":1188406710000},"page":"551-554","source":"Crossref","is-referenced-by-count":3,"title":["Does small-cell phenotype predict the natural history of prostate cancer? A case study in disease behavior"],"prefix":"10.1038","volume":"4","author":[{"given":"Susan F","family":"Slovin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFncponc0910_CR1","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/ncpuro0435","volume":"3","author":"SF Slovin","year":"2006","unstructured":"Slovin SF (2006) Neuroendocrine differentiation in prostate cancer: a sheep in wolf's clothing? Nat Clin Prac Urol 3: 138\u2013144","journal-title":"Nat Clin Prac Urol"},{"key":"BFncponc0910_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1053\/j.seminoncol.2006.10.026","volume":"34","author":"JS Palmgren","year":"2007","unstructured":"Palmgren JS  et al. (2007) Unusual and underappreciated: small cell carcinoma of the prostate. Semin Oncol 34: 22\u201329","journal-title":"Semin Oncol"},{"key":"BFncponc0910_CR3","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/j.1464-410X.2006.06041.x","volume":"97","author":"TR Asmis","year":"2005","unstructured":"Asmis TR  et al. (2005) Genitourinary small cell carcinoma: a retrospective review of treatment and survival patterns at The Ottawa Hospital Regional Cancer Center. BJU Int 97: 711\u2013715","journal-title":"BJU Int"},{"key":"BFncponc0910_CR4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3109\/00365599609182334","volume":"30","author":"H Okada","year":"1996","unstructured":"Okada H  et al. (1996) Two cases of small cell carcinoma of the prostate. Scand J Urol Nephrol 30: 503\u2013508","journal-title":"Scand J Urol Nephrol"},{"key":"BFncponc0910_CR5","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/1097-0142(197708)40:2<773::AID-CNCR2820400226>3.0.CO;2-I","volume":"40","author":"RE Wenk","year":"1977","unstructured":"Wenk RE  et al. (1977) Ectopic ACTH, prostatic oat cell carcinoma, and marked hypernatremia. Cancer 40: 773\u2013778","journal-title":"Cancer"},{"key":"BFncponc0910_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1464-410X.1991.tb15118.x","volume":"67","author":"F Adshead","year":"1991","unstructured":"Adshead F  et al. (1991) Small cell carcinoma of the prostate: implications for management. Br J Urol 67: 217\u2013218","journal-title":"Br J Urol"},{"key":"BFncponc0910_CR7","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/00000421-199708000-00011","volume":"20","author":"JH Rubenstein","year":"1997","unstructured":"Rubenstein JH  et al. (1997) Small cell anaplastic carcinoma of the prostate: seven new cases, review of the literature, and discussion of a therapeutic strategy. Am J Clin Oncol 20: 376\u2013380","journal-title":"Am J Clin Oncol"},{"key":"BFncponc0910_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.eururo.2004.09.007","volume":"47","author":"N Vashchenko","year":"2005","unstructured":"Vashchenko N and Abrahamsson PA (2005) Neuroendocrine differentiation in prostate cancer: implications for new treatment modalities. Eur Urol 47: 147\u2013155","journal-title":"Eur Urol"},{"key":"BFncponc0910_CR9","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1200\/JCO.2002.12.065","volume":"20","author":"CN Papandreou","year":"2002","unstructured":"Papandreou CN  et al. (2002) Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate. J Clin Oncol 20: 3072\u20133080","journal-title":"J Clin Oncol"},{"key":"BFncponc0910_CR10","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1200\/JCO.1993.11.4.607","volume":"11","author":"WK Kelly","year":"1993","unstructured":"Kelly WK  et al. (1993) Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer. J Clin Oncol 11: 607\u2013615","journal-title":"J Clin Oncol"},{"key":"BFncponc0910_CR11","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1080\/028418602321028292","volume":"41","author":"G Steineck","year":"2002","unstructured":"Steineck G  et al. (2002) Cytotoxic treatment of aggressive prostate tumors with or without neuroendocrine elements. Acta Oncol 41: 668\u2013674","journal-title":"Acta Oncol"},{"key":"BFncponc0910_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1677\/erc.1.00876","volume":"12","author":"A Berruti","year":"2005","unstructured":"Berruti A  et al. (2005) Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease. Endocr Relat Cancer 12: 109\u2013117","journal-title":"Endocr Relat Cancer"},{"key":"BFncponc0910_CR13","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0022-5347(05)64626-5","volume":"168","author":"DG Bostwick","year":"2002","unstructured":"Bostwick DG  et al. (2002) Neuroendocrine expression in node positive prostate cancer: correlation with systemic progression and patient survival. J Urol 168: 1204\u20131211","journal-title":"J Urol"},{"key":"BFncponc0910_CR14","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/S0022-5347(01)66261-X","volume":"155","author":"O Cussenot","year":"1996","unstructured":"Cussenot O  et al. (1996) Plasma neuroendocrine markers in patients with benign prostatic hyperplasia and prostatic carcinoma. J Urol 155: 1340\u20131343","journal-title":"J Urol"},{"key":"BFncponc0910_CR15","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/(SICI)1097-0045(19970501)31:2<110::AID-PROS6>3.0.CO;2-R","volume":"31","author":"A Angelsen","year":"1997","unstructured":"Angelsen A  et al. (1997) Use of neuroendocrine serum markers in the follow-up of patients with cancer of the prostate. Prostate 31: 110\u2013117","journal-title":"Prostate"},{"key":"BFncponc0910_CR16","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1046\/j.1464-410X.2003.t01-1-04376.x","volume":"92","author":"AJ Birtle","year":"2003","unstructured":"Birtle AJ  et al. (2003) Neuroendocrine differentiation in prostate cancer: is it detectable and treatable? BJU Int 92: 490","journal-title":"BJU Int"},{"key":"BFncponc0910_CR17","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00292-005-0791-0","volume":"26","author":"H Bonkhoff","year":"2005","unstructured":"Bonkhoff H and Fixemer T (2005) Neuroendocrine differentiation in prostate cancer: an unrecognized and therapy resistant phenotype. Pathologe 26: 453\u2013460","journal-title":"Pathologe"},{"key":"BFncponc0910_CR18","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1080\/00365590500199855","volume":"39","author":"C Petraki","year":"2005","unstructured":"Petraki C  et al. (2005) Prostate cancer with small-cell morphology: an immunophenotypic subdivision. Scand J Urol Nephrol 39: 455\u2013463","journal-title":"Scand J Urol Nephrol"}],"container-title":["Nature Clinical Practice Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncponc0910.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncponc0910","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncponc0910.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:48:36Z","timestamp":1684442916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncponc0910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["BFncponc0910"],"URL":"https:\/\/doi.org\/10.1038\/ncponc0910","relation":{},"ISSN":["1743-4254","1743-4262"],"issn-type":[{"value":"1743-4254","type":"print"},{"value":"1743-4262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}